For research and educational purposes only. Not medical advice.

RAD-140 Reference

Educational, not medical advice reference for RAD-140: SARM, Recovery; regulatory status, evidence posture, source review, and schedule notes. Also known as…

Reference summary

Phase 1 first-in-human oncology data in postmenopausal women with hormone-receptor-positive breast cancer exist; the trial excluded HER2-positive patients and did not advance to FDA approval. No body-composition human trials exist.

Categories
SARM, Recovery
Aliases
Testolone, Non-steroidal SARM
Evidence posture
human — FDA enforcement attention. Sold only as a research chemical, not for human consumption per legal seller terms. WADA-prohibited under category S1.2 anabolic agents at all times, in and out of competition. No FDA-approved drug label and no human clinical efficacy program for body-composition use. Some US states have placed RAD-140 under Schedule III; possession without a prescription may be a state-level controlled-substance offense.
Regulatory status
No FDA-approved RAD-140 drug label. FDA has issued explicit consumer warnings against SARMs in bodybuilding products. WADA prohibits RAD-140 under category S1.2 anabolic agents at all times. Several US states have placed RAD-140 under state-level Schedule III provisions; federal scheduling status varies.
Content review status
research reference

Selected public sources